APO Research
Talk to an analyst

APO RESEARCH · REPORT

Janus Kinase inhibitors (JAKi)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Janus Kinase inhibitors (JAKi) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025176 pages

Choose your research edition.

Industry ResearchJanus Kinase inhibitors (JAKi) Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Janus Kinase inhibitors (JAKi) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Janus Kinase inhibitors (JAKi) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Janus Kinase inhibitors (JAKi) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Janus Kinase inhibitors (JAKi) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Janus Kinase inhibitors (JAKi) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Janus Kinase inhibitors (JAKi) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Janus Kinase inhibitors (JAKi) include Galapagos NV, AbbVie, Pfizer Inc. and Eli Lilly and Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Janus Kinase inhibitors (JAKi) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Janus Kinase inhibitors (JAKi) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Janus Kinase inhibitors (JAKi) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Janus Kinase inhibitors (JAKi) market size, projected growth trends, production technologies, key applications, and end-use industries.

Janus Kinase inhibitors (JAKi) Segment by Company

Galapagos NV

AbbVie

Pfizer Inc.

Eli Lilly and Co.

Janus Kinase inhibitors (JAKi) Segment by Type

Upadacitinib

Tofacitinib

Filgotinib

Baricitinib

Abrocitinib

Janus Kinase inhibitors (JAKi) Segment by Application

Hospital

Clinic

Other

Janus Kinase inhibitors (JAKi) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Janus Kinase inhibitors (JAKi) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Janus Kinase inhibitors (JAKi) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Janus Kinase inhibitors (JAKi).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Janus Kinase inhibitors (JAKi) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Janus Kinase inhibitors (JAKi) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Janus Kinase inhibitors (JAKi) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Janus Kinase inhibitors (JAKi) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Janus Kinase inhibitors (JAKi) Industry Trends Table 2. Janus Kinase inhibitors (JAKi) Industry Drivers Table 3. Janus Kinase inhibitors (JAKi) Industry Opportunities and Challenges Table 4. Janus Kinase inhibitors (JAKi) Industry Restraints Table 5. Global Janus Kinase inhibitors (JAKi) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Janus Kinase inhibitors (JAKi) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers Table 9. Global Janus Kinase inhibitors (JAKi) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Janus Kinase inhibitors (JAKi) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Janus Kinase inhibitors (JAKi) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Janus Kinase inhibitors (JAKi) Manufacturers, Product Type & Application Table 13. Global Janus Kinase inhibitors (JAKi) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Janus Kinase inhibitors (JAKi) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Upadacitinib Table 17. Major Manufacturers of Tofacitinib Table 18. Major Manufacturers of Filgotinib Table 19. Major Manufacturers of Baricitinib Table 20. Major Manufacturers of Abrocitinib Table 21. Global Janus Kinase inhibitors (JAKi) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Janus Kinase inhibitors (JAKi) Sales by Type (2021-2026) & (K Units) Table 23. Global Janus Kinase inhibitors (JAKi) Sales by Type (2027-2032) & (K Units) Table 24. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021-2026) Table 25. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2027-2032) Table 26. Global Janus Kinase inhibitors (JAKi) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021-2026) & (K Units) Table 28. Global Janus Kinase inhibitors (JAKi) Revenue by Type (2027-2032) & (K Units) Table 29. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021-2026) Table 30. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Other Table 34. Global Janus Kinase inhibitors (JAKi) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Janus Kinase inhibitors (JAKi) Sales by Application (2021-2026) & (K Units) Table 36. Global Janus Kinase inhibitors (JAKi) Sales by Application (2027-2032) & (K Units) Table 37. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021-2026) Table 38. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2027-2032) Table 39. Global Janus Kinase inhibitors (JAKi) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021-2026) & (K Units) Table 41. Global Janus Kinase inhibitors (JAKi) Revenue by Application (2027-2032) & (K Units) Table 42. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021-2026) Table 43. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2027-2032) Table 44. Global Janus Kinase inhibitors (JAKi) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Janus Kinase inhibitors (JAKi) Sales by Region (2021-2026) & (K Units) Table 46. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2021-2026) Table 47. Global Janus Kinase inhibitors (JAKi) Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Janus Kinase inhibitors (JAKi) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 51. North America Janus Kinase inhibitors (JAKi) Sales by Country (2027-2032) & (K Units) Table 52. Europe Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 54. Europe Janus Kinase inhibitors (JAKi) Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2027-2032) & (K Units) Table 61. Global Janus Kinase inhibitors (JAKi) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Janus Kinase inhibitors (JAKi) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Janus Kinase inhibitors (JAKi) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2021-2026) Table 65. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2027-2032) Table 66. Galapagos NV Company Information Table 67. Galapagos NV Business Overview Table 68. Galapagos NV Janus Kinase inhibitors (JAKi) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio Table 70. Galapagos NV Recent Development Table 71. AbbVie Company Information Table 72. AbbVie Business Overview Table 73. AbbVie Janus Kinase inhibitors (JAKi) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio Table 75. AbbVie Recent Development Table 76. Pfizer Inc. Company Information Table 77. Pfizer Inc. Business Overview Table 78. Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio Table 80. Pfizer Inc. Recent Development Table 81. Eli Lilly and Co. Company Information Table 82. Eli Lilly and Co. Business Overview Table 83. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio Table 85. Eli Lilly and Co. Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. Janus Kinase inhibitors (JAKi) Distributors List Table 89. Janus Kinase inhibitors (JAKi) Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Janus Kinase inhibitors (JAKi) Product Image Figure 2. Global Janus Kinase inhibitors (JAKi) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Janus Kinase inhibitors (JAKi) Market Size (2021-2032) & (US$ Million) Figure 4. Global Janus Kinase inhibitors (JAKi) Sales (2021-2032) & (K Units) Figure 5. Global Janus Kinase inhibitors (JAKi) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Janus Kinase inhibitors (JAKi) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Upadacitinib Image Figure 9. Tofacitinib Image Figure 10. Filgotinib Image Figure 11. Baricitinib Image Figure 12. Abrocitinib Image Figure 13. Global Janus Kinase inhibitors (JAKi) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Janus Kinase inhibitors (JAKi) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021-2032) Figure 16. Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Janus Kinase inhibitors (JAKi) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global Janus Kinase inhibitors (JAKi) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Janus Kinase inhibitors (JAKi) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021-2032) Figure 25. Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Janus Kinase inhibitors (JAKi) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021-2032) Figure 28. North America Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2032) Figure 30. U.S. Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2032) Figure 35. Germany Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2032) Figure 42. China Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021-2032) Figure 50. Brazil Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Janus Kinase inhibitors (JAKi) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Janus Kinase inhibitors (JAKi) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Janus Kinase inhibitors (JAKi) Revenue (2021-2032) & (US$ Million) Figure 61. North America Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Janus Kinase inhibitors (JAKi) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Janus Kinase inhibitors (JAKi) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Janus Kinase inhibitors (JAKi) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Janus Kinase inhibitors (JAKi) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Upadacitinib
  • Tofacitinib
  • Filgotinib
  • Baricitinib
  • Abrocitinib
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Galapagos NV
  • AbbVie
  • Pfizer Inc.
  • Eli Lilly and Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Janus Kinase inhibitors (JAKi) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Janus Kinase inhibitors (JAKi) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Janus Kinase inhibitors (JAKi) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Janus Kinase inhibitors (JAKi) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Janus Kinase inhibitors (JAKi) Market Dynamics
  1. 2.1 Janus Kinase inhibitors (JAKi) Industry Trends
  2. 2.2 Janus Kinase inhibitors (JAKi) Industry Drivers
  3. 2.3 Janus Kinase inhibitors (JAKi) Industry Opportunities and Challenges
  4. 2.4 Janus Kinase inhibitors (JAKi) Industry Restraints
3 Janus Kinase inhibitors (JAKi) Market by Manufacturers
  1. 3.1 Global Janus Kinase inhibitors (JAKi) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Janus Kinase inhibitors (JAKi) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Janus Kinase inhibitors (JAKi) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Janus Kinase inhibitors (JAKi) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Janus Kinase inhibitors (JAKi) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Janus Kinase inhibitors (JAKi) Manufacturers, Product Type & Application
  7. 3.7 Global Janus Kinase inhibitors (JAKi) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Janus Kinase inhibitors (JAKi) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Janus Kinase inhibitors (JAKi) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Janus Kinase inhibitors (JAKi) Tier 1, Tier 2, and Tier 3
4 Janus Kinase inhibitors (JAKi) Market by Type
  1. 4.1 Janus Kinase inhibitors (JAKi) Type Introduction
  2. 4.1.1 Upadacitinib
  3. 4.1.2 Tofacitinib
  4. 4.1.3 Filgotinib
  5. 4.1.4 Baricitinib
  6. 4.1.5 Abrocitinib
  7. 4.2 Global Janus Kinase inhibitors (JAKi) Sales by Type
  8. 4.2.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Janus Kinase inhibitors (JAKi) Sales by Type (2021-2032)
  10. 4.2.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Janus Kinase inhibitors (JAKi) Revenue by Type
  12. 4.3.1 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021-2032)
  14. 4.3.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021-2032)
5 Janus Kinase inhibitors (JAKi) Market by Application
  1. 5.1 Janus Kinase inhibitors (JAKi) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Janus Kinase inhibitors (JAKi) Sales by Application
  6. 5.2.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Janus Kinase inhibitors (JAKi) Sales by Application (2021-2032)
  8. 5.2.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Janus Kinase inhibitors (JAKi) Revenue by Application
  10. 5.3.1 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021-2032)
  12. 5.3.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021-2032)
6 Global Janus Kinase inhibitors (JAKi) Sales by Region
  1. 6.1 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Janus Kinase inhibitors (JAKi) Sales by Region (2021-2032)
  3. 6.2.1 Global Janus Kinase inhibitors (JAKi) Sales by Region (2021-2026)
  4. 6.2.2 Global Janus Kinase inhibitors (JAKi) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Janus Kinase inhibitors (JAKi) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Janus Kinase inhibitors (JAKi) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Janus Kinase inhibitors (JAKi) Revenue by Region
  1. 7.1 Global Janus Kinase inhibitors (JAKi) Revenue by Region
  2. 7.1.1 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Janus Kinase inhibitors (JAKi) Revenue by Region (2021-2026)
  4. 7.1.3 Global Janus Kinase inhibitors (JAKi) Revenue by Region (2027-2032)
  5. 7.1.4 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Janus Kinase inhibitors (JAKi) Revenue (2021-2032)
  8. 7.2.2 North America Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Janus Kinase inhibitors (JAKi) Revenue (2021-2032)
  11. 7.3.2 Europe Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Janus Kinase inhibitors (JAKi) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Galapagos NV
  2. 8.1.1 Galapagos NV Company Information
  3. 8.1.2 Galapagos NV Business Overview
  4. 8.1.3 Galapagos NV Janus Kinase inhibitors (JAKi) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio
  6. 8.1.5 Galapagos NV Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Janus Kinase inhibitors (JAKi) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 Eli Lilly and Co.
  20. 8.4.1 Eli Lilly and Co. Company Information
  21. 8.4.2 Eli Lilly and Co. Business Overview
  22. 8.4.3 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio
  24. 8.4.5 Eli Lilly and Co. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Janus Kinase inhibitors (JAKi) Value Chain Analysis
  2. 9.1.1 Janus Kinase inhibitors (JAKi) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Janus Kinase inhibitors (JAKi) Production Mode & Process
  6. 9.2 Janus Kinase inhibitors (JAKi) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Janus Kinase inhibitors (JAKi) Distributors
  9. 9.2.3 Janus Kinase inhibitors (JAKi) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst